Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
113.10
-0.51 (-0.45%)
At close: Mar 4, 2026, 4:00 PM EST
113.00
-0.10 (-0.09%)
After-hours: Mar 4, 2026, 7:59 PM EST
Abbott Laboratories Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Abbott Laboratories stock have an average target of 141, with a low estimate of 125 and a high estimate of 154. The average target predicts an increase of 24.67% from the current stock price of 113.10.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 2, 2026.
Analyst Ratings
The average analyst rating for Abbott Laboratories stock from 18 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 8 |
| Buy | 8 | 7 | 7 | 7 | 8 | 8 |
| Hold | 3 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 18 | 18 | 18 | 19 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $169 → $142 | Buy | Maintains | $169 → $142 | +25.55% | Feb 2, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $155 → $140 | Strong Buy | Maintains | $155 → $140 | +23.78% | Jan 23, 2026 |
| Bernstein | Bernstein | Buy Maintains $154 → $125 | Buy | Maintains | $154 → $125 | +10.52% | Jan 23, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $147 → $135 | Buy | Maintains | $147 → $135 | +19.36% | Jan 23, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $140 → $132 | Buy | Maintains | $140 → $132 | +16.71% | Jan 23, 2026 |
Financial Forecast
Revenue This Year
48.28B
from 44.33B
Increased by 8.92%
Revenue Next Year
51.85B
from 48.28B
Increased by 7.39%
EPS This Year
5.74
from 3.72
Increased by 54.37%
EPS Next Year
6.32
from 5.74
Increased by 10.03%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 50.7B | 54.6B | |||
| Avg | 48.3B | 51.9B | |||
| Low | 46.4B | 49.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 14.3% | 13.2% | |||
| Avg | 8.9% | 7.4% | |||
| Low | 4.6% | 3.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 6.06 | 6.67 | |||
| Avg | 5.74 | 6.32 | |||
| Low | 5.52 | 5.97 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 62.9% | 16.1% | |||
| Avg | 54.4% | 10.0% | |||
| Low | 48.3% | 3.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.